The Associated Press
NEW YORK — Drugmaker Pfizer Inc. is aiming to boost sales of veterinary medicines in China — and its global dominance in the animal health business — via a joint venture with a Chinese startup company.
Pfizer said that it has reached a deal to jointly develop, manufacture and sell vaccines for animals with Jilin Guoyan Animal Health Company Ltd.
The joint venture, called Jilin Pfizer Guoyuan Animal Health Co., plans to start marketing its first product — a vaccine against a reproductive and respiratory condition pigs get — next year.
Executives from Pfizer and the Chinese company are reviewing options and. . .
Register or Login to keep reading
Thank you for your interest in accessing the complete content. To continue reading, please register for free. By registering, you'll gain full access to our valuable resources, updates, and insights.
If you already have an account please Log In.
